Figure 1: Preparation of Glycerol/Adipic Acid. Hyperbranched Poly(ester)/Salicylic Acid Conjugate.
Introduction
Hyperbranched poly(ester)s produced from nontoxic, renewable biosources offer great potential for the delivery of therapeutic agents. In general, hyperbranched poly(ester)s have been produced from multifunctional monomers without regard for gelation (coatings industry) or with reaction conditions determined empirically to avoid gelation [1] [2] [3] [4] [5] [6] . This approach does not permit reproducibility of polymer molecular weight, dispersity, structure or level of end group functionality. It lacks economy in time and reagents, is not amenable to scale-up, and is intellectually unsatisfying. A better method is needed for the generation of delivery vehicles and has been developed [7] [8] [9] .
For the polymerization of monomers containing functional groups of unequal reactivity, e.g. glycerol (the primary hydroxyl groups of glycerol are approximately 1.4 times as reactive in esterification as is the secondary hydroxyl group) traditional gelation theory is inadequate for selecting appropriate monomer ratios (ratios of reactive functional groups) to assure a well-defined, non-gelling structure at high monomer conversion [7] . However, the Mascosko-Miller conditional probability model is suitable for this purpose [10] [11] [12] . This approach has been demonstrated for the synthesis of hyperbranched poly(ester)s from a range of bio monomers [7] [8] [9] . Using Macosko-Miller theory an appropriate ratio of monomers may be selected to avoid gelation at high conversion and to ensure the presence of desired endgroups for the attachment of therapeutic agents [8] . This is illustrated below for the generation of a salicylate prodrug suitable for controlled release of the active component.
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A Naproxen conjugate may be prepared in an analogous manner. A glycerol/succinic acid hyperbranched poly(ester) may also be used for the preparation of similar prodrugs. Salicylic acid is a common therapeutic used for the treatment of acne and inflammation [13] [14] [15] . Controlled release of the active agent from the drug/polymer conjugate would enhance the duration of effectiveness while minimizing skin irritation. Release of the active agent occurs smoothly from either conjugate under either chemical or enzymatic (rat liver microsomes) catalysis. 
